This study is collecting blood, urine, and skin samples from people with cutaneous T-cell lymphoma (CTCL), Sezary Syndrome, Mycosis Fungoides, eczema, or atopic dermatitis. The goal is to create a resource for current and future research into these conditions. Researchers will use these samples to study things like immune system responses, how tumors grow or shrink, and genetic and protein information. This will help advance treatments for CTCL. The study is looking for 200 participants who are 18 or older and have one of these diagnoses. The main way they will measure success is by studying the proteins found in CTCL samples over time. The current recruitment status is unclear.

Study design

This is an observational study, meaning researchers will collect samples and information without giving any new treatments. It aims to enroll 200 participants.

What's involved

You may have up to 9 blood draws per year, each taking 60 ml of blood. You might also have one skin biopsy up to 4 times a year, and provide urine samples.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, proteomics of Cutaneous T-cell lymphoma, is measured at "Ongoing," so follow-up duration is not precisely defined.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.